Financhill
Back

Gitlab, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison

Sell
21

GTLB
Gitlab, Inc.

Last Price:
$39.06
Seasonality Move:
4.37%
Sell
50

ARWR
Arrowhead Pharmaceuticals, Inc.

Last Price:
$68.58
Seasonality Move:
40.49%
Sell
21
Gitlab, Inc. (GTLB) is a Sell

Is Gitlab, Inc. a Buy, Sell or Hold?

  • The current Gitlab, Inc. [GTLB] share price is $39.07. The Score for GTLB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Sell

Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.60. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GTLB Stock Price Chart

What is Gitlab, Inc.'s stock price today?

  • The Gitlab, Inc. share price today is $39.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing slight buying pressure.

ARWR Stock Price Chart

What is Arrowhead Pharmaceuticals, Inc.'s stock price today?

  • The Arrowhead Pharmaceuticals, Inc. share price today is $68.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.03 Sell
Relative Strength Index (14 RSI): 38.83 Sell
Chaikin Money Flow: 625552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.83 - 46.31) Sell
Bollinger Bands (100): (42.34 - 48.6) Sell

ARWR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.94 Buy
Relative Strength Index (14 RSI): 75.92 Buy
Chaikin Money Flow: 249389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.15 - 56.87) Buy
Bollinger Bands (100): (20.01 - 44.73) Buy

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.74 Sell
20-day SMA: 42.12 Sell
50-day SMA: 44.94 Sell
200-day SMA: 46.67 Sell
8-day EMA: 39.55 Sell
20-day EMA: 41.65 Sell
50-day EMA: 43.98 Sell
200-day EMA: 47.44 Sell

ARWR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.55 Buy
20-day SMA: 48.94 Buy
50-day SMA: 42.23 Buy
200-day SMA: 23.8 Buy
8-day EMA: 60.08 Buy
20-day EMA: 52.14 Buy
50-day EMA: 43.49 Buy
200-day EMA: 29.21 Buy

Gitlab, Inc. Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.

Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.

Gitlab, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arrowhead Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):